| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Anemia and thrombocytopenia in patients undergoing chemotherapy for solid tumors: A descriptive study of a large outpatient oncology practice database, 2000–2007
|
Wu, Ying
|
|
2009
|
31 |
P2 |
p. 2416-2432
17 p.
|
artikel
|
| 2 |
Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-hodgkin lymphoma
|
Dennie, Trevor W.
|
|
2009
|
31 |
P2 |
p. 2290-2311
22 p.
|
artikel
|
| 3 |
Clinically significant drug—drug interactions between oral anticancer agents and nonanticancer agents: A delphi survey of oncology pharmacists
|
Chan, Alexandre
|
|
2009
|
31 |
P2 |
p. 2379-2386
8 p.
|
artikel
|
| 4 |
Cost-effectiveness of pentostatin compared with cladribine in the management of hairy cell leukemia in the United Kingdom
|
Guest, Julian F.
|
|
2009
|
31 |
P2 |
p. 2398-2415
18 p.
|
artikel
|
| 5 |
Cost-minimization analysis of sequence changes between FOLFIRI and FOLFOX6 therapy for advanced colorectal cancer in Japan
|
Miyazaki, Yoshiko
|
|
2009
|
31 |
P2 |
p. 2433-2441
9 p.
|
artikel
|
| 6 |
Current and emerging therapies for acute myeloid leukemia
|
Robak, Tadeusz
|
|
2009
|
31 |
P2 |
p. 2349-2370
22 p.
|
artikel
|
| 7 |
Degarelix: A gonadotropin-releasing hormone antagonist for the management of prostate cancer
|
Steinberg, Michael
|
|
2009
|
31 |
P2 |
p. 2312-2331
20 p.
|
artikel
|
| 8 |
Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: A prospective, multicenter, open-label, randomized, two-way crossover drug—drug interaction study
|
Venkatakrishnan, Karthik
|
|
2009
|
31 |
P2 |
p. 2444-2458
15 p.
|
artikel
|
| 9 |
Effects of hepatic impairment on the pharmacokinetics of nilotinib: An open-label, single-dose, parallel-group study
|
Yin, Ophelia Q.P.
|
|
2009
|
31 |
P2 |
p. 2459-2469
11 p.
|
artikel
|
| 10 |
High-dose estrogen as salvage hormonal therapy for highly refractory metastatic breast cancer: A retrospective chart review
|
Mahtani, Reshma L.
|
|
2009
|
31 |
P2 |
p. 2371-2378
8 p.
|
artikel
|
| 11 |
Lapatinib: A small-molecule inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor—2 tyrosine kinases used in the treatment of breast cancer
|
Tevaarwerk, Amye J.
|
|
2009
|
31 |
P2 |
p. 2332-2348
17 p.
|
artikel
|
| 12 |
Retrospective comparison of neutropenia in children with ewing sarcoma treated with chemotherapy and granulocyte colony-stimulating factor (G-CSF) or pegylated G-CSF
|
Milano-Bausset, Emilie
|
|
2009
|
31 |
P2 |
p. 2388-2395
8 p.
|
artikel
|
| 13 |
Review of the contemporary cytotoxic and biologic combinations available for the treatment of metastatic breast cancer
|
Tkaczuk, Katherine H. Rak
|
|
2009
|
31 |
P2 |
p. 2273-2289
17 p.
|
artikel
|
Tijdschrift beschrijving